Until 2018, people with CVD who also suffered from migraines had no medical options for stopping a migraine in progress. Neither nonsteroidal anti-inflammatory drugs (NSAIDs) nor serotonin 5HT-1B/1D receptor agonists (“triptans”)—the first-line drugs for treating migraine—were considered safe for them to use.
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
